Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model

By              

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 933-938

Spandidos Publications

Access to resources Recommend Favorite

Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

By Cabioglu Neslihan   Sahin Aysegul   Doucet Michele   Yavuz Ekrem   Igci Abdullah   O.Yildirim Engin   Aktas Esin   Bilgic Sema   Kiran Bayram   Deniz Gunnur   Price Janet  

Clinical and Experimental Metastasis, Vol. 22, Iss. 1, 2005-03 ,pp. : 39-46

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the combined expression of chemokine SDF-1α and its receptor CXCR4 as a prognostic marker for gastric cancer

By                        

Experimental and Therapeutic Medicine, Vol. 2, Iss. 3, 2011-01 ,pp. : 499-504

Spandidos Publications

Access to resources Recommend Favorite

RNA interference suppression of Nogo-66 receptor prevents Nogo-66-mediated inhibition of invasion and adhesion and simultaneously increases cell apoptosis in C6 cells

By      

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2171-2178

Spandidos Publications

Access to resources Recommend Favorite

Effect of CXCL12/CXCR4 on increasing the metastatic potential of nonsmall cell lung cancer in vitro is inhibited through the downregulation of CXCR4 chemokine receptor expression

By                  

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 941-947

Spandidos Publications

Access to resources Recommend Favorite